胎儿纤维连接蛋白检测疑似早产ppt课件.pptVIP

Fetal Fibronectin Testing for Suspected Preterm Labour;Fetal Fibronectin Testing for Suspected Preterm Labour ;Preterm Labour ( 37 weeks);Preterm Birth;Rate of Preterm Delivery by Province/Territory (excluding Ontario) 2000;Add own provincial data;The Challenge…;Source: CPSS Report 2003 p. 74;How do we identify who is at Risk?;;Risk Assessment Markers;Potential Benefits of An Evidence-Based, Risk Assessment Marker; Fetal Fibronectin (fFN) is not new in obstetrics practice 1st literature appeared in 1985; as an oncogene marker. 1st OB-specific literature appeared in 1991 in New England J. of Medicine by Lockwood, et al. 200 peer reviewed OB articles now published, 3 meta analyses, 9 Canada-specific abstracts presented at SOGC. Canada specific data documents reduced medication use, reduced hospital day stays, reduced transports Canadian data is from level III hospitals, rural and remote hospitals. ;What is Fetal Fibronectin (?FN);Fetal Fibronectin (?FN);Normal ?FN Expression by Gestational Age;Key Terminologyfor Evaluating PTD Diagnostics;Utility of ?FN for Predicting PTB in Symptomatic Women;1/125 Deliver 14 days;Nova Scotia Pilot Study April 2002-March 2004 (Armson Scott et. al.);Conclusions from Nova Scotia Study;Conclusions from Nova Scotia Study;Results from the Nova Scotia Study;BC Study;Of 62 patients tested, outcomes were known for 47 patients. ;BC Study Results;BC Study Conclusion;Cost Savings (literature);Resource Utilization - Canada;_________________________________________________________ Baseline Period Study Period p value _________________________________________________________ Patients 116 116 Preterm Births 9 (7.8%) 10 (8.6%) NS PTL Admissions 28 (24.1%) 14 (12.1%) 0.02 Days Hospitalized 145 28 Mean LOS 5.2 0.6 0.01 Admission Costs $102,660 $26,169 Mean Cost $3,666 $581 0.01 Abenhaim, JOGC